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Previously, we demonstrated that pretreatment of cells with interferon (IFN) a 1 g or b 1 g inhibited dengue virus (DV)
replication. In this study, experiments were performed to better define the mechanism by which IFN blocks the accumulation
of dengue virus (DV) RNA. Pretreatment of human hepatoma cells with IFN b 1 g did not significantly alter virus attachment,
viral entry, or nucleocapsid penetration into the cytoplasm. The inhibitory effect of IFN was retained even when naked DV
RNA was transfected directly into cells, confirming that steps associated with viral entry were not the primary target of IFN
action. Biosynthetic labeling experiments revealed that IFN abolished the translation of infectious viral RNA that occurred
prior to RNA replication. Subcellular fractionation experiments demonstrated that IFN did not significantly alter the ability of
viral RNA to attach to ribosomes. The antiviral effect of IFN appeared independent of the IFN-induced, double-stranded
RNA-activated protein kinase (PKR) and RNase L, as genetically deficient PKR2 RNase L2 cells that were infected by DV
retained sensitivity to inhibition by IFN. We conclude that IFN prevents DV infection by inhibiting translation of the infectious
viral RNA through a novel, PKR-independent mechanism. © 2001 Academic PressKey Words: dengue; virus; interferon; translation; nucleocapsid; ribosome; superinfection; flavivirus; replication; RNA-
activated protein kinase (PKR).
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iINTRODUCTION
Dengue fever (DF), the most prevalent arthropod-
borne viral illness in humans, is caused by dengue virus
(DV), a member of the Flaviviridae family of positive-
stranded RNA enveloped viruses. The four serotypes of
DV (DV1–4) are transmitted to humans by mosquitoes,
and infection causes a spectrum of clinical disease rang-
ing from an acute debilitating, self-limited febrile illness
(DF) to a life-threatening syndrome (dengue hemorrhagic
fever/dengue shock syndrome (DHF/DSS)). DV causes
disease globally, with an estimated 100 million cases of
DF and 250,000 cases of DHF/DSS per year (Monath,
1994). Despite its potential for worldwide morbidity and
mortality, the pathogenesis of DV-induced disease is not
well understood, and surprisingly little is known about
the effects and mechanisms of antiviral agents.
In a primary infection, DV enters target cells after its
envelope protein (E) binds to an uncharacterized cell
surface receptor that may display heparan sulfate moi-
eties (Chen et al., 1997). As with other flaviviruses, viral
1 Current address: Departments of Medicine, Molecular Microbiol-
gy, Pathology, and Immunology, Washington University School of Med-
cine, 660 South Euclid Avenue, Box 8230, St. Louis, MO 63110.
2 To whom correspondence and reprint requests should be ad-
dressed at School of Public Health, 140 Warren Hall, University of
t
e
California, Berkeley, Berkeley, CA 94720-7360. Fax: (510) 642-6350.
E-mail: eharris@socrates.berkeley.edu.
297uptake is believed to occur through receptor-mediated
endocytosis in clathrin-coated vesicles (Chambers et al.,
1990). These vesicles fuse with endosomes, where an
acid-catalyzed conformational change in E, in associa-
tion with the membrane protein M, results in membrane
fusion and the release of the nucleocapsid into the cy-
toplasm (Heinz et al., 1994a,b). It is believed that nucleo-
capsids associate with cytosolic ribosomes and then
migrate and dock at the rough endoplasmic reticulum
(RER) (Singh and Helenius, 1992; Singh et al., 1997).
Translation of the input strand ensues, and after the
replication complex is assembled, negative-strand RNA
and positive-strand RNA are replicated (Khromykh et al.,
1999, 2000). Subsequently, there is proliferation of virus-
containing membrane structures (Chu and Westaway,
1992) and production of progeny virus (Westaway, 1987).
For many viruses, an initial step in the establishment
of infection is overcoming the innate antiviral response
provided by the cellular interferon (IFN) system. IFN a
and b are secreted by virus-infected cells and exhibit
multiple biologic properties including antiproliferative,
antiviral, and immunomodulatory effects (Platanias et al.,
1996; Stark et al., 1998). IFN g is secreted by activated T
ymphocytes and NK cells and has antiviral activity di-
ectly through the induction of effector molecules and
ndirectly through enhanced antigen presentation and
he induction of apoptosis (Boehm et al., 1997). Antiviral
ffector molecules that are induced by IFN include dou-
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298 DIAMOND AND HARRISble-stranded RNA-activated protein kinase (PKR) (Der
and Lau, 1995; Katze, 1995; Meurs et al., 1990), 29,59-
oligoadenylate synthetase (29,59-OAS) (Hovanessian,
1991), RNase L (Hassel et al., 1993; Zhou et al., 1993),
double-stranded RNA-activated adenosine deaminase
(Bass et al., 1989), MxA and MxB (Landis et al., 1998;
Muller et al., 1992; Zurcher et al., 1992), guanylate bind-
ing protein (GBP)-1 (Anderson et al., 1999), and nitric
xide (Karupiah et al., 1993; Lin et al., 1997). Although
everal studies show that IFN modulates infection of
laviviridae family members, the mechanism has been
uggested in only two cases, Japanese encephalitis vi-
us (JEV) and hepatitis C virus (HCV). IFN g is reported to
block JEV infection in macrophages through the produc-
tion of nitric oxide (Karupiah et al., 1993; Lin et al., 1997).
FN a may inhibit HCV infection through activation of PKR
and cessation of protein translation (Gale et al., 1997,
1998; Gale and Katze, 1998; Taylor et al., 1999).
Recently, we demonstrated that infection of human
cells in vitro by DV was prevented by pretreatment of
cells with pharmacologically relevant concentrations of
IFN a, b, or g (Diamond et al., 2000a). By using asym-
etric quantitative RT-PCR, we showed that despite the
resence of large quantities of positive-strand DV RNA in
FN-pretreated cells, the accumulation of negative-strand
NA was blocked, and productive infection was aborted.
owever, these studies did not address the mechanism
f IFN-mediated inhibition—whether the block was tran-
criptional, translational, or possibly at an earlier step in
he DV life cycle. Our prior studies also established that
retreatment with IFN was required for complete inhibi-
ion of viral RNA, antigen, and virion production, as a
ignificant percentage of the inhibitory effect was lost if
ells were treated with IFN a few hours after infection.
In this report, we utilized virus binding and internaliza-
ion assays, nucleocapsid penetration assays, subcellu-
ar fractionation techniques, RNA transfection, and bio-
ynthetic labeling experiments to localize the step in the
V life cycle that was inhibited by IFN. In sequential
nfection experiments that explored the basis for why
retreatment of cells with IFN was required for complete
nhibition, we found that although the addition of IFN a
ew hours after infection modestly inhibited the primary
irus, it blocked infection by a superinfecting DV strain.
e describe a model in which IFN protects cells against
e novo DV infection by preventing translation of the
nput viral RNA but is inefficient at neutralizing an estab-
ished infection.
RESULTS
dentification of the step at which IFN inhibits DV
nfection
DV binding and entry. Previously, we demonstrated
hat pretreatment of human cells with a combination of
FN a 1 g or b 1 g significantly inhibited DV infection byreventing the accumulation of negative-strand viral RNA
Diamond et al., 2000a). Because IFN could be blocking
egative-strand replication either directly or indirectly by
nhibiting early steps in the viral entry process, experi-
ents were designed to identify the step in the virus life
ycle that was impeded by IFN. To assess whether IFN
ffected DV type 2 (DV2) attachment to cells, two types of
xperiments were performed. HepG2 cells were pre-
reated for 24 h with IFN b 1 g and exposed to DV2 at
0°C to allow binding but prevent internalization. After
extensive washing, bound virus was detected with anti-
DV2 antibodies (Bielefeldt-Ohmann, 1998) or by quanti-
tating the number of copies of viral RNA bound to cells.
Pretreatment with individual or combinations of IFN b 1
g had no effect on the percentage of HepG2 cells that
ound DV2, the amount of virus that was adsorbed to
ndividual cells, or the number of copies of positive-
trand viral RNA bound to cells (Fig. 1; and data not
hown).
To determine whether IFN affected virus internaliza-
ion, HepG2 cells that were pretreated with IFN b 1 g or
medium were exposed to DV2 at 0 or 37°C. After several
hours, unbound virus was removed by washing, and the
cells were treated with an alkaline solution of high salt
concentration (pH 9.5, 1 M NaCl) at 0°C. This solution
disrupts noncovalent interactions between the virus and
the cell in the extracellular environment yet is not toxic to
cells when used for less than 5 min (M. Diamond and E.
Harris, unpublished observations). Treatment with the
alkaline salt solution did not alter the amount of positive-
strand viral RNA detected in cells incubated with virus at
FIG. 1. Effect of IFN on DV2 binding and internalization in HepG2
cells. Cells were pretreated with medium or IFN (b 1 g) for 24 h. DV2
was bound for 2 h at either 37 or 0°C. Subsequently, all cells were
cooled to 0°C, free virus was removed by washing, and in some cases
cells were exposed to 1 M NaCl and 50 mM Na2CO3 pH 9.5, for 3 min.
Cells were lysed, and RNA was measured by competitive RT-PCR. The
data are expressed as the number of copies of viral RNA per cell and
are the average of three experiments. The error bars represent stan-
dard deviations.37°C but decreased the levels by 90–95% in cells ex-
posed to virus at 0°C (Fig. 1). Thus, cells that were
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299IFN PREVENTS TRANSLATION OF INFECTIOUS DV RNAincubated at 37°C were resistant to removal of viral RNA
by washing with the alkaline salt solution because the
virus had already entered the cell. Moreover, pretreat-
ment with IFN b 1 g did not affect viral entry because
here was no difference in the amount of viral RNA that
as associated with IFN- or medium-treated cells at
7°C after exposure to the high-salt wash.
Nucleocapsid escape from endosomes. Flaviviruses
re believed to enter cells by receptor-mediated endo-
ytosis (Gollins and Porterfield, 1986; Heinz et al., 1994a).
cidification of the endosome induces conformational
hanges in the E protein and nucleocapsid transit into
he cytoplasm. To determine whether IFN altered nucleo-
apsid penetration into the cytoplasm, an endosomal
scape assay (Marsh et al., 1983; Singh and Helenius,
1992) was developed for DV. Functionally intact [3H]uri-
dine-labeled DV2 was isolated by sucrose gradient ul-
tracentrifugation (see Materials and Methods). HepG2
cells were pretreated for 24 h with IFN b 1 g or medium
nd incubated with 3H-labeled DV2 for 8 h at 37°C. This
ime point was selected because it was the earliest point
t which de novo synthesis of DV antigen was detected
(see below), a process that requires nucleocapsid pen-
etration into the cytoplasm. Unbound virus was removed
by extensive washing, and the cells were subjected to a
procedure that disrupted the plasma membranes but
maintained endosomal integrity (Harms et al., 1980;
Marsh et al., 1983). Subsequently, the lysate was incu-
bated with ribonucleases. Cytosolic viral RNA and nu-
cleocapsids are highly sensitive to degradation by ribo-
nucleases (Kaariainen and Soderlund, 1971; Marsh et al.,
1983), whereas viral RNA in endosomal compartments is
protected from degradation. After ribonuclease treat-
ment, intracellular contents were subjected to TCA pre-
cipitation, and the supernatants (which contain degraded
[3H]uridine-labeled RNA) were quantitated after scintilla-
ion counting. Although pretreatment of HepG2 with IFN
b 1 g modestly reduced the amount of viral RNA exiting
rom endosomes at 8 h (medium, 33 6 4%; IFN b 1 g,
25 6 2%), this small difference could not account for the
dramatic effect of IFN on the levels of viral antigen,
negative-strand RNA, and progeny virus.
Replication of transfected viral RNA. Since it appeared
that IFN did not abolish DV infection by blocking nucleo-
capsid penetration, we questioned whether it inhibited
nucleocapsid uncoating, a step that occurs either imme-
diately prior to or concomitant with ribosome docking
(Singh and Helenius, 1992; Wengler, 1984). To assess
this, an indirect assay that used naked viral RNA was
designed. We reasoned that if the predominant mecha-
nism for IFN inhibition was at the level of nucleocapsid
uncoating, then IFN should not significantly inhibit neg-
ative-strand replication in cells that were transfected
with purified viral RNA in the absence of viral proteins.
DV2 RNA was purified from intact virions under denatur-
ing conditions and transfected into K562 erythroleukemic
w
tcells with cationic liposomes (DMRIE-C) or electropora-
tion. In liposome-mediated transfection, RNA enters cells
via an endocytic pathway (Friend et al., 1996; Wrobel and
Collins, 1995) that is distinct from natural DV infection,
whereas with electroporation, it is introduced directly
into the cytoplasm. K562 cells were used instead of
HepG2 cells because they demonstrated a similar pat-
tern of IFN-mediated inhibition of DV2 infection (Diamond
et al., 2000a) and were easier to transfect with viral RNA.
In the presence of medium alone, significant levels of
negative-strand viral RNA accumulated within the cells,
and infectious virus was produced in cell supernatants
(Fig. 2). In contrast, pretreatment of K562 cells with IFN
b 1 g abolished the increase in negative-strand viral
RNA and the production of infectious virus regardless of
whether the viral RNA was introduced by liposomes or
electroporation. Notably, significant levels of positive-
strand viral RNA were detected in the IFN-treated cells,
confirming that viral RNA entered these cells but was not
able to replicate efficiently.
Input strand translation. Because IFN blocked accu-
mulation of the negative strand of viral RNA in cells
infected with intact virus or transfected with naked
RNA, three possible mechanisms were hypothesized:
IFN inhibited input strand translation, directly blocked
the viral RNA-dependent RNA polymerase, or activated
a ribonuclease that degraded viral RNA. To investigate
whether IFN affected input strand translation, HepG2
cells were pretreated with IFN b 1 g or medium alone
for 24 h, infected with DV2, pulsed with [35S]cysteine–
ethionine for times (4, 8, or 20 h) that corresponded
o points early in the infection process, lysed, and
mmunoprecipitated with antibodies to the E protein.
n HepG2 cells, the early time points (4 and 8 h)
recede an increase in positive-strand viral RNA (Di-
mond et al., 2000a) such that protein synthesis re-
lects the initial phase of input strand translation. In
ontrast, the later time point (20 h) is accompanied by
log increase in positive-strand viral RNA (Diamond et
l., 2000a) and thus heralds the amplification phase of
rotein synthesis. In HepG2 cells pretreated with me-
ium, synthesis of E protein was detected at 8 and
0 h after the pulse but not at the 4-h time point (Fig.
A; and data not shown). In contrast, in cells pre-
reated with IFN b 1 g, there was no evidence of
synthesis of DV2 E protein at any of the time points.
The inhibitory effect of IFN b 1 g on input strand
ranslation was confirmed in independent pulse-label-
ng experiments (Fig. 3B). At 12 h after infection, cells
ere pulse-labeled for 20 min with [35S]cysteine–me-
hionine. Nascent synthesis of viral proteins (e.g., NS5
nd NS3) was detected in cells that were pretreated
ith medium but not in uninfected cells or cells pre-
reated with IFN b 1 g.
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300 DIAMOND AND HARRISMechanism of IFN inhibition of viral RNA translation
Although pretreatment of cells with IFN blocked trans-
lation of the input strand of DV2 RNA, the mechanism
remained unclear. We postulated that IFN could block
viral RNA translation by preventing attachment of the
viral RNA to ribosomes, by blocking the initiation or
elongation steps in translation, or alternatively by rapidly
FIG. 2. Transfection of K562 cells with DV2 RNA: effect of IFN on RNA
replication and virus production. K562 cells were pretreated for 24 h
with medium or IFN b 1 g. Cells were transfected with equivalent
mounts of purified DV RNA using cationic liposomes or electropora-
ion. (A) Seventy-two hours after transfection, cells were harvested,
otal RNA was isolated, and quantitative asymmetric RT-PCR was
erformed to determine the amount of positive and negative viral RNA.
B) Supernatants were harvested for plaque assays in BHK21 cells. The
ata are expressed as the number of copies of viral RNA per cell or the
umber of plaque-forming units per milliliter. The data are the average
f three experiments, and the error bars indicate standard deviations.
value of zero is indicated by asterisks.degrading viral RNA. To begin to address these hypoth-
eses, the effect of IFN on the intracellular levels of viral
w
vRNA was assessed after infection. HepG2 cells were
pretreated for 24 h with medium or a combination of IFN
b 1 g, exposed to DV2, harvested at various time points
fter infection, and analyzed for positive-strand viral
NA. At the early time points that preceded RNA repli-
ation (4, 6, and 12 h postinfection), the levels of positive-
trand RNA in medium- and IFN b 1 g-treated cells were
quivalent (Diamond et al., 2000a). Rapid degradation of
iral RNA was not observed in the RNA transfection
xperiments in IFN-treated K562 cells or in time-course
tudies that assessed the stability of [3H]uridine-labeled
V after binding (data not shown). Moreover, in experi-
ents with cells that were genetically deficient in the
FN-activated RNase L, IFN retained its ability to block
V infection (see below). Thus, IFN did not appear to
FIG. 3. Biosynthetic labeling and immunoprecipitation of DV2 pro-
teins. (A) HepG2 cells were pretreated for 24 h with medium or IFN b 1
g, incubated with DV2, and exposed to medium containing [35S]cys-
teine–methionine. At 8 and 20 h after infection, cells were harvested,
lysed with 1% Triton X-100, and immunoprecipitated with antibody–
Sepharose against the E protein of DV2 and DV3. Samples were
resolved by 10% SDS–PAGE and autoradiography. Mr indicates the
molecular weight standards, and the arrow corresponds to the migra-
tion of the E protein. (B) HepG2 cells were pretreated for 24 h with
medium or IFN b 1 g. Cells were either not infected (U) or infected with
V2 at an m.o.i. of 200. After the indicated times, cells were pulse-
abeled with medium containing [35S]cysteine–methionine for 20 min.
fter washing, cells were lysed in 1% Triton X-100, and the proteins
ere resolved by 6% SDS–PAGE and autoradiography. The migration of
iral proteins (arrows) was confirmed by Western blot (not shown).
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301IFN PREVENTS TRANSLATION OF INFECTIOUS DV RNAblock input strand translation by activating an RNase that
rapidly degraded DV RNA.
To begin to assess how IFN blocked translation of the
infectious DV RNA, subcellular fractionation studies
were undertaken. HepG2 cells that were pretreated with
either medium or IFN b 1 g were infected with DV2 for
10 h at 37°C. In untreated cells, 10 h is close to the
earliest time point at which input strand viral RNA trans-
lation is observed but prior to de novo accumulation of
positive- or negative-strand viral RNA. At the end of the
incubation, the protein synthesis inhibitor cycloheximide
was added for 10 min to inhibit elongation and stabilize
viral RNA association with ribosomes and polysomes
FIG. 4. Subcellular fractionation after DV2 infection. HepG2 cells wer
nd treated with cycloheximide for 10 min, and then plasma membranes
n a 15–45% continuous sucrose gradient. (A) The bottom of the grad
ometric and formaldehyde gel analysis to determine the polysome, 80S
f detergent-solubilized, purified DV nucleocapsids. (B) Total RNA was
ubjected to quantitative RT-PCR. The data are the average of three e(Baliga et al., 1969). After cell lysis in the presence of
protease and RNase inhibitors, the soluble cytosolic con-stituents were separated by sucrose gradient ultracen-
trifugation, and the ribosomes and polysomes were re-
solved (Fig. 4A). 80S ribosomes and polysomes were
distinguished by their sedimentation velocity, absor-
bance at 280 and 260 nm, and presence of the 28S and
18S rRNA in formaldehyde gels (data not shown). Inde-
pendent experiments with detergent-solubilized DV2 re-
vealed that purified nucleocapsids did not cosediment
with polysomes or ribosomes but instead migrated at
140S (data not shown), similar to the sedimentation rates
observed with Semliki Forest virus (Singh and Helenius,
1992). To determine the effect of IFN on the association
of viral RNA with cytosolic ribosomes, RNA was har-
eated for 24 h with medium or IFN b 1 g, incubated with DV2 for 10 h,
isrupted by manual lysis. The cytosolic contents were ultracentrifuged
gins at the left of the graph. Fractions were subjected to spectropho-
nd 9S peaks. The 140S peak corresponds to the sedimentation velocity
d from the input cytosol, polysomes, 80S, and 9S peak fractions and
ents, and the error bars represent standard deviations.e pretr
were d
ient be
, 60S, avested from the fractions that corresponded to the peaks
of polysomes, 80S ribosomes, and 9S cellular RNA and
D
w
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302 DIAMOND AND HARRISsubjected to competitive RT-PCR. Pretreatment with IFN
b 1 g only modestly diminished the amount of viral RNA
associated with cytosolic polysomes but did not appear
to affect viral RNA interaction with the 80S ribosomes
(Fig. 4B).
PKR is an IFN-induced, double-stranded RNA-acti-
vated protein kinase that phosphorylates translation ini-
tiation factor eIF2a, resulting in the arrest of protein
translation (Dever et al., 1993; Meurs et al., 1990). Be-
cause it has antiviral activity against members of the
picornavirus and rhabodvirus families of RNA viruses
(Meurs et al., 1992; Yang et al., 1995; Zhou et al., 1999),
and is hypothesized to be a target of IFN resistance by
HCV (Gale et al., 1997; Taylor et al., 1999), we investi-
gated the role of PKR in IFN-mediated inhibition of DV
infection. Murine embryonal fibroblasts that were wild
type, genetically deficient in PKR alone, or deficient in
PKR, RNase L and Mx1 were pretreated with medium or
murine IFN a or b (2.5–2500 IU/ml) for 24 h, exposed to
V2, and harvested 72 h after infection. In murine cells,
hich have an innate resistance to flaviviruses (Brinton,
983; Brinton et al., 1982), addition of IFN g was not
required to achieve complete inhibition of antigen or
virus production. Immunoblotting experiments confirmed
that the genetically deficient embryonal fibroblasts pro-
duced no PKR protein before or after IFN stimulation
(data not shown). Although a deficiency of PKR in these
cells resulted in a loss of the IFN-mediated antiviral
effect against encephalomyocarditis virus (EMCV) and
vesicular stomatitis virus (VSV) (Zhou et al., 1999), the
absence of PKR or RNase L by themselves or as a triply
deficient combination (PKR2 RNase L2 and Mx12) did
not attenuate the inhibition of DV infection mediated by
IFN b (Fig. 5; and data not shown) or IFN a (data not
shown).
Effect of IFN on sequential DV infections
We reported previously that pretreatment with IFN was
required to observe complete inhibition of DV infection in
several different cell types, including HepG2 cells (Dia-
mond et al., 2000a). Treatment of HepG2 cells with IFN
b 1 g 4 h after exposure to DV2 resulted in a significant
loss of IFN-mediated inhibition (51% reduction compared
to 98% reduction). We hypothesized two models to ex-
plain this: (i) IFN protected against de novo infection but
not against an established infection by impeding an early
step in the infection process or (ii) DV actively disrupted
the antiviral effect of IFN. Our experiments demonstrat-
ing that IFN inhibited DV infection at input strand trans-
lation favored the first hypothesis. However, to test the
latter model, we assessed the effect of IFN on a super-
infecting virus of a different serotype, DV4, added after an
established DV2 infection. Several controls were per-
formed. First, HepG2 cells that were treated with IFN b 1
g 4 h after exposure to virus exhibited a significant loss
m
wof IFN-mediated inhibition of DV4 (60% reduction at 4 h
after infection compared to 98% reduction at 4 h prior to
infection; see Fig. 6A). Thus, the kinetics of IFN-mediated
inhibition of DV4 were similar to those observed with
DV2. Second, a sequential infection time course was
performed with DV2 and DV4 in the absence of IFN. At
early time points (0 to 8 h), there was little effect of the
first virus on the superinfecting strain, whereas at later
time points (.12 h), infection with the first strain inhibited
infection by the second strain (Fig. 6B). This effect of
homologous viral interference has been described for
flaviviruses and alphaviruses, is time- and multiplicity of
infection (m.o.i.)-dependent, and occurs by an as yet
uncharacterized mechanism that is independent of IFN
(Hunt and Marcus, 1974; Johnston et al., 1974; Mifune and
Makino, 1974; Sujak and Kawecki, 1976).
To test our hypothesis and minimize viral interference
between DV serotypes, the following experiment was
performed. HepG2 cells were infected with the first DV
strain (DV2 or DV4) for 4 h, exposed to IFN b 1 g or
FIG. 5. Effect of IFN b on DV2 infection in murine embryonal fibro-
blasts. Fibroblasts that were wild type, deficient in PKR, or triply defi-
cient in PKR, RNase L, and Mx1 were pretreated for 24 h with medium
or varying concentrations of murine IFN b (2.5 to 2500 IU/ml), exposed
to DV2, and incubated for 72 h. (A) Cells were harvested and processed
for flow cytometry as described in the legend to Fig. 1. (B) Supernatants
were harvested for plaque assay as described in the legend to Fig. 3.
The data are the average of three experiments, and the error bars
represent standard deviations.edium for an additional 4 h, and finally, superinfected
ith the second strain 8 h after infection with the primary
h ith ant
c ressed
303IFN PREVENTS TRANSLATION OF INFECTIOUS DV RNAstrain. Forty-eight hours later, cells were harvested and
processed by flow cytometry to detect the percentage of
cells expressing DV2 and DV4 antigens. Although the
inhibitory effect against the initial strain was markedly
attenuated as expected, IFN treatment 4 h after the first
serotype but 4 h before the superinfecting viral serotype
virtually abolished infection of the superinfecting strain
(Fig. 6C). Because IFN blocked infection of the superin-
FIG. 6. Sequential infection experiments with DV2 and DV4. (A) Hep
h) infection with DV2 or DV4. Cells were harvested, stained with eithe
expressed as described in the legend to Fig. 1. (B) HepG2 cells were ex
exposed to the superinfecting strain, DV2. Forty-eight hours later, cells
flow cytometry. The data are expressed as described in the legend to
4 h. Subsequently, medium or IFN b 1 g was added for 4 h, and then
ours after the initial infection, cells were harvested, immunostained w
ourse of infection is depicted below the graph, and the data are expfecting virus, it appears unlikely that the loss in IFN-
mediated inhibition of the primary virus observed overtime was due to an active disruption of the antiviral
effector pathway.
DISCUSSION
In most cases, IFN mediates its antiviral effect through
induction of a series of molecules that influence the
intracellular trafficking, transcription, translation, assem-
ls were treated with medium or IFN b 1 g before (24 h) or after (14
V2 or anti-DV4 mAbs, and processed by flow cytometry. The data are
to medium or the primary strain, DV4. After a specified time, cells were
arvested, stained with anti-DV2 and anti-DV4 mAbs, and processed by
C) HepG2 cells were infected with the primary strain (DV2 or DV4) for
erinfecting strain (DV4 or DV2, as indicated) was added. Seventy-two
i-DV2 and anti-DV4 mAbs, and processed by flow cytometry. The time
as described in the legend to Fig. 1.G2 cel
r anti-D
posed
were h
Fig. 1. (
the supbly, and budding of viruses (Gale and Katze, 1998; Kochs
and Haller, 1999; Stark et al., 1998). In a prior study, we
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304 DIAMOND AND HARRISdemonstrated that IFN a 1 g or b 1 g profoundly
inhibited DV infection by preventing the accumulation of
negative-strand viral RNA (Diamond et al., 2000a). It was
unclear whether this occurred directly by blocking RNA-
dependent RNA transcription or by stimulating viral RNA
degradation or indirectly by inhibiting earlier steps in the
viral infection pathway. In this report, we demonstrate
that IFN blocks the accumulation of negative-strand viral
RNA by inhibiting the translation of the input strand of
viral RNA. This conclusion is based on evidence from
several experiments that assessed the effect of IFN
pretreatment on the early steps in the pathway of DV
infection. Because the inhibitory effect of IFN was still
observed after transfection of naked viral RNA, we hy-
pothesized that the antiviral action occurred at a step
subsequent to the release of the viral genome into the
cytoplasm. Biosynthetic labeling experiments corrobo-
rated this, as pretreatment of cells with IFN b 1 g
abolished the initial phase of translation of input viral
RNA that occurs prior to the replication of viral RNA.
Finally, subcellular fractionation studies suggested that
IFN inhibits the synthesis of DV proteins from the input
strand of viral RNA by disrupting a step subsequent to
FIG. 6the binding of ribosomes and the initiation of translation.
The lack of viral protein translation did not appear tobe due to the rapid degradation of infectious DV RNA.
Intracellular levels of viral RNA were not significantly
different in medium- and IFN-treated cells at the time
points that preceded replication of viral RNA. Moreover,
experiments with genetically deficient cells demon-
strated that expression of RNase L was not required for
the inhibitory effect of IFN on DV infection. We suggest
that prior to viral replication, single-stranded, infectious
DV RNA that is released into the cytoplasm may not
sufficiently activate the double-strand-dependent 29,59-
AS. Low levels of 29,59-oligoadenylates would explain
he absence of an antiviral role of RNase L in preventing
V infection in IFN-treated cells. Studies that assess the
ffect of DV infection on the accumulation of 2959 oli-
goadenylates at early time points will address this hy-
pothesis directly.
IFN inhibits the infection pathway of positive-, nega-
tive-, and double-stranded RNA viruses through the gen-
eration and activation of an array of antiviral effector
molecules. The induction of the Mx family of GTPases
interferes with viral propagation (Frese et al., 1996; Lan-
dis et al., 1998; Pavlovic et al., 1990, 1995; Zhao et al.,
1996), possibly by blocking the intracellular trafficking of
inuednucleocapsids (Kochs and Haller, 1999). Expression of
GBP-1 mediates an antiviral effect against VSV and
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305IFN PREVENTS TRANSLATION OF INFECTIOUS DV RNAEMCV (Anderson et al., 1999). The production of 29,59-
oligoadenylates (Hassel et al., 1993; Hovanessian, 1991;
Zhou et al., 1993) activates RNase L and attenuates the
infection of picornaviruses (Alarcon et al., 1984; Chebath
et al., 1987; Li et al., 1998) by degrading viral RNA. The
synthesis and activation of PKR lead to the phosphory-
lation of the eukaryotic translation initiation factor eIF2a
and the subsequent arrest of protein synthesis (De
Benedetti and Baglioni, 1984; De Benedetti et al.,
1985a,b; Meurs et al., 1992; Miyamoto and Samuel, 1980;
Samuel et al., 1980). To date, the only suggested mech-
anisms for the inhibition of the Flaviviridae family mem-
bers are through the production of nitric oxide and PKR.
Ectopic expression of nitric oxide blocked Japanese en-
cephalitis virus infection (Karupiah et al., 1993; Lin et al.,
1997), and treatment with the nitric oxide synthetase
inhibitor N-monomethyl-L-arginine blocked the IFN g-in-
uced attenuation of JEV infection (Lin et al., 1997). Re-
istance to IFN a therapy among HCV genotypes corre-
ated with variation in a discrete region of NS5A (Eno-
oto et al., 1996). Ectopic expression of HCV NS5A
epressed PKR activation, and NS5A variants that exhib-
ted decreased binding to PKR in vitro were associated
ith clinical sensitivity to IFN a (Gale et al., 1997, 1998;
Gale and Katze, 1998). Although both HCV envelope and
nonstructural proteins interact with and inhibit PKR ac-
tivity (Gale et al., 1997; Taylor et al., 1999), the lack of an
dequate in vitro or in vivo model makes it uncertain how
FN and PKR inhibit HCV infection (Francois et al., 2000).
The evidence shown in this study points to a novel
echanism by which IFN pretreatment of cells inhibits
V infection. Although prior studies with VSV, a negative-
trand RNA rhabdovirus, and EMCV, a positive-strand
icornavirus, implicate translation as a critical check-
oint for IFN action, only PKR has been described as an
ntiviral effector molecule that functions at this stage
Zhou et al., 1999). In the present study, murine fibro-
lasts that were genetically deficient in PKR and infected
ith DV2 retained sensitivity to both IFN a and b. In
contrast, these same PKR-deficient fibroblasts lost the
majority of the IFN-mediated antiviral effect against
EMCV and VSV (Zhou et al., 1999). Consistent with this,
U937 human myelomonocytic cells that expressed anti-
sense constructs of PKR (Yeung et al., 1996) were still
sensitive to IFN b 1 g-mediated inhibition of DV2 infec-
tion (M. Diamond, A. Lau, and E. Harris, unpublished
data). We conclude that although translation of the input
strand is blocked by IFN, it is apparently through a
PKR-independent mechanism. Although eIF2a could still
articipate in the IFN-induced inhibition if it were phos-
horylated by other cellular kinases (e.g., the endoplas-
ic reticulum-resident kinase PERK and human GCN2
IF2a kinase) (Harding et al., 2000; Sood et al., 2000a,b),
the formation of polysomes that contain DV RNA sug-
gests that translation is inhibited after initiation. Studies
that assess the phosphorylation of eIF2a after IFN treat-ent in PKR2 murine embryonal fibroblasts should clar-
ify the role of eIF2a in mediating the translational block
of DV infection.
In a prior study, we observed that pretreatment of cells
with IFN was required for complete inhibition of viral
RNA, antigen, and virion production (Diamond et al.,
2000a). A significant percentage of the inhibitory effect
was lost if cells were treated a few hours after infection.
Two models were devised to explain these results: IFN
protects against de novo viral infection but cannot im-
pede an established infection because it inhibits at an
early step in the intracellular viral life cycle, or DV actively
interrupts the antiviral effect of IFN. The data from the
subcellular fractionation and sequential infection exper-
iments support a model of viral replication in which in the
absence of IFN, infectious viral RNA binds to ribosomes
in the cytosol and forms a translation initiation complex.
Polysomes are generated but translation likely pauses
after a short polypeptide is synthesized because of mem-
brane anchor signals in the capsid protein of the DV
genome (Markoff et al., 1997). Polysomes that are asso-
ciated with DV RNA and the nascent protein are subse-
quently recruited to membrane structures, where trans-
lation continues. We speculate that pretreatment of cells
with IFN b 1 g induces a novel cytosolic antiviral effector
molecule that blocks translation of the input strand of
viral RNA either by impairing the elongation phase of
translation or by preventing a functional association of
cytosolic polysomes that contain viral RNA with the RER.
However, if the viral RNA and associated polysomes
reach the RER prior to contact with this putative cytosolic
inhibitor, translation ensues and the complex becomes
inaccessible to the inhibitor. This model is consistent
with our sequential infection experiments that demon-
strate that IFN treatment 4 h after primary virus infection
but 4 h before superinfecting virus infection has a partial
inhibitory effect on the primary virus and a complete
inhibitory effect on the secondary virus. We hypothesize
that IFN efficiently prevents the spread of DV to unin-
fected cells by preventing translation of the infectious DV
viral RNA, but, apart from its immunomodulatory effects,
is much less adept at neutralizing an established infec-
tion because it blocks an early step in the viral life cycle.
Definitive proof of this model awaits characterization
of the IFN-induced molecules that mediate this antiviral
effector function; recent oligonucleotide array analysis in
cells pretreated with IFN a, b, or g may help to identify
candidate molecules (Der et al., 1998). Our model also
predicts the existence of particular sequence or struc-
tural motifs in the input strand viral RNA that the IFN-
induced antiviral molecule recognizes as part of the
process of aborting input strand translation. Two candi-
date regions of DV that are highly conserved and may
associate with ribosomes are the 59 and 39 untranslated
regions. These regions form a series of secondary struc-
tures that are unique to many positive-stranded RNA
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306 DIAMOND AND HARRISviruses but are not present in mammalian 59 and 39 RNA
sequences (Chambers et al., 1990). Experiments with the
Venezuelan equine encephalitis alphavirus have demon-
strated that inherent resistance of epizootic isolates to
IFN a and b correlated with virulence in vivo and with
sequences in the 59 untranslated region (Spotts et al.,
1998). Moreover, the translation elongation factor EF1a
binds to a stem loop motif in the 39 untranslated region
of the West Nile encephalitis virus (Blackwell and Brin-
ton, 1997), and a similar region has been shown to
regulate translation of HCV RNA (Ito and Lai, 1999; Ito et
al., 1998). Recently, we have isolated a series of DV
variants that are 25- to 50-fold resistant to the effects of
IFN. Studies are under way to identify the motifs that
determine interferon sensitivity. The presence of such
features in other flaviviruses, as well as more distantly
related positive-strand RNA alphaviruses and picornavi-
ruses, may predict the extent to which this mechanism of
IFN-mediated inhibition is used to combat viral infec-
tions.
MATERIALS AND METHODS
Cell culture, antibodies, and virus stocks
Human, hamster, and mosquito cells were cultured as
described previously (Diamond et al., 2000a). Murine
embryonal fibroblasts (wild type, deficient in PKR or
RNase L, and triply deficient in PKR, RNase L, and Mx1;
gift of R. Silverman and B. Williams, Cleveland, OH (Zhou
et al., 1999)) were maintained in Dulbecco’s modified
Eagle’s medium (DMEM, Gibco BRL, Grand Island, NY),
supplemented with 20% FBS, 100 U/ml penicillin G, and
100 mg/ml streptomycin at 37°C in 5% CO2 and used for
6–8 passages. Murine hybridomas against dengue virus
envelope proteins (3H5-1, anti-DV2; 5D4-11, anti-DV3)
were cultured as described previously (Diamond et al.,
2000a). Antibodies were purified by protein A affinity
chromatography and coupled to cyanogen–bromide ac-
tivated Sepharose CL-4B (Pharmacia, Piscataway, NJ).
For immunostaining, purified IgG was used at 10–20
mg/ml, and tissue culture supernatants were used at a
1/4 final dilution. The DV2 (16681 (Russell and Nisalak,
1967)) and DV4 (703-4 (Wang et al., 2000)) strains used in
this study were kindly provided by the Centers for Dis-
ease Control and Prevention (Fort Collins, CO). Viral
strains 16681 and 703-4 were isolated from human pa-
tients in Thailand in 1964 and 1994, respectively. All
experiments used viral stocks from the same tissue
culture passage; viral stocks were obtained as described
previously (Diamond et al., 2000a).
Flow cytometric and viral plaque assays
To determine the percentage of cells that expressed
viral antigen, flow cytometric analysis was performed as
described previously (Diamond et al., 2000a,b). Virus
m
mproduction was determined by plaque assays using
BHK21 cells (Diamond et al., 2000a,b), and virus concen-
trations were determined as plaque-forming units per
milliliter (PFU/ml).
Cell infection with virus
HepG2 cells were infected with DV2 as described
previously (Diamond et al., 2000a). In some experiments,
cells were pretreated with individual or combinations of
IFN (IFN b at 10 ng/ml (20 IU/ml) and IFN g at 10 ng/ml
(30 IU/ml)) before (24 or 4 h) infection. In some of the
sequential infection studies, IFN was added to cells after
DV infection (4 h). In the viral interference time-course
experiments, HepG2 cells were infected with the primary
DV strain at an m.o.i. of 3. After a specified time, the cells
were then exposed to a second DV viral strain at an m.o.i.
of 3. Forty-eight hours after the second infection, cells
were harvested and processed for detection of viral
antigens. For experiments with the murine embryonal
fibroblasts, wild-type and deficient cells were plated
(1.25 3 105 cells/well), allowed to adhere, and then stim-
ulated for 24 h with recombinant murine IFN b (PBL
iomedical Laboratories, New Brunswick, NJ; 2.5 to 2500
U/ml) or hybrid recombinant human IFN a A/D (PBL
iomedical Laboratories; 5 to 5000 IU/ml). Subsequently,
mbryonal fibroblasts were infected with DV2 at an m.o.i.
f 50, incubated at 37°C for 2 h, and 72 h later, cells and
upernatants were harvested. A high m.o.i. was required
or infection because of an IFN-independent flavivirus
esistance that is observed in mouse-derived cells and
orrelates with a mutation in the Flv gene locus of chro-
osome 5 (Brinton, 1983; Brinton et al., 1982; Sangster et
l., 1994).
ell transfection with RNA
K562 cells were transfected with purified RNA using
ationic liposomes or electroporation. RNA was purified
rom DV2 viral supernatants (3 3 108 PFU) after extrac-
tion in guanidinium isothiocyanate using the RNEasy
Mini Kit (Qiagen, Valencia, CA) and eluted in RNase-free
ddH2O. For liposome-mediated transfection, the cationic
ipid reagent DMRIE-C (1,2-dimyristyloxypropyl-3-di-
ethyl-hydroxy ethyl ammonium bromide and choles-
erol in a 1:1 ratio) was used according to the manufac-
urer’s instructions (Gibco BRL). Briefly, K562 cells that
ere pretreated for 24 h with medium or IFN b 1 g (10
ng/ml each) were washed in Opti-MEM I medium (Gibco
BRL) and plated (5 3 105 cells per well) in a 12-well plate.
iposomes were prepared by adding 12 ml of DMRIE-C to
1 ml of Opti-MEM I medium and mixing gently. Immedi-
ately after, purified DV2 RNA (15 ml per condition) was
dded, and the RNA–liposome suspension was incu-
ated with K562 cells for 6 h at 37°C. Subsequently, the
edium containing the liposome suspension was re-
oved, and complete medium (RPMI supplemented with
c
v
w
s
1
a
s
n
c
v
C
r
u
(
d
d
p
p
p
(
(
1
P
v
f
f
(
u
m
E
p
(
307IFN PREVENTS TRANSLATION OF INFECTIOUS DV RNA10% FBS) was added. Cells and supernatants were har-
vested 72 h later for plaque assay, flow cytometric anal-
ysis, and viral RNA determination. Electroporation of DV2
RNA was performed as previously described (Kinney et
al., 1997) with the following modifications. K562 cells that
were pretreated for 24 h with medium or IFN b 1 g (10
ng/ml each) were washed twice in RNase-free PBS
(Gibco BRL) at 4°C. Cells were resuspended (1 3 106
cells in 500 ml) in PBS, DV2 RNA was added (15 ml per
ondition), and the mixture was placed in 0.2-cm cu-
ettes (Bio-Rad, Hercules, CA) for 10 min on ice. Cells
ere electroporated at 960 mF, 0.26 kV, and infinite re-
istance. Cells were allowed to recover in the cuvette for
0 min at room temperature, washed once with RPMI,
nd plated in individual wells of a 24-well plate in RPMI
upplemented with 20% FBS for 72 h. Cells and super-
atants were harvested 72 h later for plaque assay, flow
ytometric analysis, and positive- and negative-strand
iral RNA determination.
ompetitive reverse transcriptase-polymerase chain
eaction (RT-PCR)
Positive- and negative-strand DV RNA was measured
sing a previously described competitive RT-PCR assay
Diamond et al., 2000a). The amount of viral RNA was
etermined from the competitor concentration that pro-
uced competitor and DV bands of equal intensity. RNA
er cell was calculated as follows: Copies of viral RNA
er cell 5 [(competitor concentration in copies per ml)
(total volume of RNA/volume of RNA in RT-PCR reac-
tion)]/(total number of cells).
Preparation of [3H]uridine-labeled DV2
The purification of radiolabeled virus was based on
rotocols for the purification of Semliki Forest alphavirus
Kaariainen and Soderlund, 1971) and West Nile flavivirus
Gollins and Porterfield, 1984). Briefly, C6/36 cells (5 3
06) were infected with DV2 at an m.o.i. of 10 and incu-
bated for 36 h at 28°C. Free virus was removed after 5
washes with L15 medium, and then the cells were pre-
treated with actinomycin D (1 mg/ml) for 2 h at 28°C.
Subsequently, [3H]5,6-uridine (40 mCi/ml, Amersham–
harmacia) was added for 48 h at 28°C. Radiolabeled
irus supernatants were harvested, centrifuged at 900 g
or 5 min at 4°C to remove cells, microfuged at 10,000 g
or 30 min at 4°C to remove cellular debris, pelleted
18,000 rpm 3 2.5 h), and loaded onto a 15–52% contin-
ous sucrose gradient (in 20 mM Tris–HCl, pH 7.8, 130
M NaCl, and 1 mM EDTA) in 16 3 102 mm ultracentri-
fuge tubes (Seton Scientific, Los Gatos, CA). The gradi-
ents were placed in a SW-28 swinging bucket rotor and
ultracentrifuged for 2.5 h at 25,000 rpm (100,000 g) at
4°C. Subsequently, the bottom of the tube was punctured
with a flamed 21-gauge needle, and fractions (0.7 ml)
were collected manually by droplet. Samples were as-sayed for buoyant density by refractometry, radioactivity
after precipitation with trichloroacetic acid (TCA) and
scintillation counting, and viral titer by plaque assay in
BHK21 cells. Fractions that had peak viral titers and TCA
precipitable counts corresponded to a 23% sucrose so-
lution. Routinely, 50 to 80% of input radiolabeled virus
was recovered in the two peak fractions. Purity of the
virus was confirmed by SDS–PAGE and fluorographic
analysis in parallel experiments using [35S]cysteine–me-
thionine-labeled DV2 (M. Diamond, T. Shoemaker, and E.
Harris, unpublished observations). Specific activity was
calculated after TCA precipitation and plaque assay and
averaged between 0.6 3 103 and 1.1 3 103 PFU/cpm.
ndosome escape assay
The endosome escape assay was a modification of
ublished protocols for the Semliki Forest alphavirus
Marsh et al., 1983; Singh et al., 1997). Briefly, HepG2
cells (6 3 106) that were treated for 24 h with medium or
IFN b 1 g (10 ng/ml each) were detached with iced PBS
supplemented with 5 mM EDTA and washed in L15
supplemented with 5% FBS. [3H]Uridine-labeled DV2 (200
ml, 6 3 103 cpm) was added to medium- or IFN-treated
cells and incubated for 8 h at 37°C. Subsequently, cells
were iced, washed twice with L15 at 4°C, and washed
once with 250 mM sucrose, 10 mM triethanolamine, and
10 mM acetic acid, pH 7.5 (STA buffer). The last wash
was performed at 3000 g for 10 min at 4°C because of
the increased density of the STA buffer. Cells were re-
suspended gently (0.5 ml) in STA buffer supplemented
with 1 mM EDTA and manually lysed on ice by 25 passes
through a 25-gauge needle. This treatment disrupts the
plasma membrane but leaves .95% of endosomes intact
(Marsh et al., 1983). Cytosolic contents were divided into
three pools: one that received no treatment (negative
control), a second that was exposed to RNase A (4 Kuntz
units per reaction) and micrococcal nuclease (0.5 units
per reaction), and a third that was exposed to 1% Triton
X-100, RNase A, and micrococcal nuclease. After being
incubated for 45 min at 37°C, TCA was added to a final
concentration of 10%, and the reactions were placed on
ice for 30 min and precipitated by microfuging for 10 min
at 14,000 rpm at 4°C. Supernatants were harvested and
mixed with 10 ml of UniverSol ES scintillation fluid (ICN
Pharmaceuticals, Costa Mesa, CA), and radioactivity
was measured. The percentage of virus that escaped the
endosome was determined by dividing the cpm recov-
ered from the TCA supernatant of cytosolic fraction that
was treated with RNase by the cpm from the cytosolic
fraction treated with Triton X-100 and RNase.
Subcellular fractionation studies
The association of viral RNA with cytosolic polysomes
and ribosomes was performed based on published pro-
tocols (Ramaiah et al., 1992; Seiser and Nicchitta, 2000).
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308 DIAMOND AND HARRISHepG2 cells (3 3 106) were treated with medium or IFN
b 1 g (10 ng/ml each) for 24 h. Cells were then incubated
ith DV2 at an m.o.i. of 25 for 10 h in 4 ml of RPMI 1640
upplemented with 5% FBS at 37°C. At the end of the
ncubation period, cycloheximide (200 mM) was added
for 10 min to prevent the elongation phase of translation
and stabilize RNA–ribosome initiation complexes. Cells
were cooled to 4°C and detached with Hanks’ balanced
salt solution (HBSS) containing 5 mM EDTA; free virus
was removed after three washes at 4°C with RPMI, 5%
FBS. The cells were then washed once in 50 mM Tris–
HCl, pH 8.0, containing 100 mM NaCl and 10 mM MgCl2
(TMN buffer) and resuspended in 500 ml of TMN buffer.
nhibitors of proteases (1 mM phenylmethylsulfonyl fluo-
ide) and RNases (2 U/ml, Super RNasin, Ambion, Austin,
X) were added, and the plasma membrane was dis-
upted by manual lysis as described above (Marsh et al.,
983; Singh et al., 1997). The tubes were rinsed with an
additional 500 ml of TMN, and the lysate was loaded onto
a 15–45% continuous sucrose gradient in TMN and ul-
tracentrifuged in an SW-28 swinging bucket rotor at
25,000 rpm (100,000 g) for 5 h. Fractions (24 per tube)
were collected by droplet as described above. Aliquots
of each fraction were measured by spectrophotometry
(Ultraspec 1000, Pharmacia) at 280 and 260 nm to deter-
mine the elution peaks that corresponded to polysomes,
the 80S and 60S ribosome fractions, and 9S cytosolic
RNA. In separate experiments, ribosome identity was
confirmed by demonstration of 28S and 18S rRNA in the
peak fractions by formaldehyde gel and ethidium bro-
mide staining (data not shown). From the fractions cor-
responding to the polysomes, 80S ribosomes, and 9S
RNA, aliquots (0.1 ml) were harvested and RNA was
extracted with the RNEasy Mini Kit. Subsequently, posi-
tive-strand viral RNA was measured by asymmetric com-
petitive RT-PCR.
Virus binding and internalization assays
For virus binding and internalization assays, HepG2
cells were pretreated with IFN b 1 g or medium for 24 h,
etached with HBSS and 5 mM EDTA, and washed into
PMI supplemented with 5% FBS at 4°C. Cells (1 3 106)
ere divided into microcentrifuge tubes, mixed with DV2
m.o.i. of 10), and incubated at either 0 or 37°C for 4 h
ith occasional agitation to avoid pelleting. Subse-
uently, all samples were iced, washed three times with
PMI and 5% FBS at 4°C, washed once with PBS at 4°C,
nd exposed to either PBS or 1 M NaCl and 50 mM
a2CO3, pH 9.5, at 0°C for 3 min. An equal volume (500
ml) of PBS was immediately added, and the cells were
washed one additional time in PBS at 4°C. After final
centrifugation, the supernatant was removed, RNA was
harvested, and competitive RT-PCR was performed to
detect positive-strand DV2 RNA in each of the samples.
The immunofluorescence virus binding assay was based
e
son a previously published protocol (Bielefeldt-Ohmann,
1998). Twenty-four hours prior to the assay HepG2 cells
were treated with medium or IFN b and g. HepG2 cells
were harvested after removal with HBSS, 5 mM EDTA,
washed twice in RPMI, 5% FBS, and chilled on ice for 15
min. Cells (3 3 105 in 50 ml) were added to individual
wells of a 96-well plate and incubated with DV2 (strain
16681) at an m.o.i. of 150 for 2 h on ice. Subsequently,
free virus was removed after five washes with iced RPMI,
5% FBS. Bound virus was labeled with specific mAbs
(anti-DV2 or anti-DV3) for 1 h on ice followed by three
washes in iced RPMI, 5% FBS. Subsequently, virus–anti-
body complexes were incubated with FITC goat anti-
mouse IgG for 45 min on ice, washed three times with
iced RPMI, 5% FBS, and fixed in 1% paraformaldehyde in
PBS. Virus bound to cells was detected by flow cytometry
as described above. The specificity of this binding assay
has been demonstrated previously using recombinant
Dengue proteins as inhibitors of virus binding (Bielefeldt-
Ohmann, 1998; Bielefeldt-Ohmann et al., 1997).
Biosynthetic labeling and immunoprecipitation
For immunoprecipitation experiments, HepG2 cells
(2 3 106) were plated and pretreated for 24 h with IFN
b 1 g or medium. Cells were washed once, infected with
DV2 (m.o.i. of 20 in a-MEM with 2% FBS) for 4 h at 37°C,
ashed three times in RPMI with 5% FBS and twice in
PMI that was deficient in cysteine and methionine
RPMI Cys2Met2, Sigma Chemical), and incubated in
.75 ml of RPMI Cys2Met2 medium supplemented with
5% dialyzed FBS and 0.5 mCi of [35S]cysteine–methionine
(Redivue ProMix, Amserham–Pharmacia) for 4, 8, or 20 h.
Subsequently, cells were detached with HBSS and 5 mM
EDTA, washed in PBS at 4°C, and resuspended in 1 ml of
lysis buffer (1% Triton X-100, 140 mM NaCl, 25 mM
Tris–HCl, pH 7.8, 0.025% NaN3, 1 mM phenylmethylsul-
onyl fluoride, 2 mg/ml iodacetamide, 0.2 TIU/ml aproti-
in, and 0.5% bovine hemoglobin). Lysis proceeded for
h by incubating the solution at 4°C. Subsequently,
uclear debris was removed by centrifugation (3000 g for
min), and membrane fragments were removed by mi-
rocentrifugation (10,000 g for 10 min). The clarified ly-
ate (1 ml) was precleared with bovine IgG–Sepharose
200 ml, 10 mg/ml) for 4 h on a rotary shaker and then
mmunoprecipitated overnight with anti-DV2– or anti-
V3–Sepharose (25 ml of 2 mg/ml stock) in a volume of
500 ml (200 ml labeled lysate 1 300 ml of 140 mM NaCl,
25 mM Tris–HCl, pH 7.8, and 0.025% NaN3 (TSA) contain-
ing 0.1% Triton X-100 at 4°C). Immunoprecipitations were
washed at 4°C three times with 0.1% Triton X-100 with
TSA, washed once with TSA, washed once with 50 mM
Tris–HCl, pH 6.8, and resuspended in 20 ml of SDS
sample buffer. After being boiled for 5 min, b-mercapto-thanol was added (5% final concentration), and the
amples were resolved by 10% SDS–polyacrylamide gel
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309IFN PREVENTS TRANSLATION OF INFECTIOUS DV RNAelectrophoresis. The gel was fixed, exposed to Amplify
reagent (Amersham–Pharmacia) for 30 min, dried, and
subjected to autoradiography at 280°C.
For pulse-labeling, published protocols were modified
(Baxt and Bablanian, 1976; Baxt et al., 1977). HepG2 cells
were plated (2.0 3 105) and pretreated for 24 h with IFN
b 1 g or medium. Cells were washed, infected with DV2
m.o.i. of 200) for 7, 11, or 23 h, washed three times in
PMI Cys2Met2 medium supplemented with 5% dialyzed
FBS, and incubated for 1 h. Subsequently, 0.1 mCi of
[35S]cysteine–methionine was added for 20 min. Cells
ere then washed three times in PBS, detached with
BSS and 5 mM EDTA, pelleted, and lysed in 0.2 ml of
ysis buffer on ice. After 15 min, the lysate was clarified
y centrifugation at 10,000 g (10 min at 4°C). SDS sample
buffer with 5% b-mercaptoethanol was added to an ali-
quot (40 ml) of the clarified lysate and subjected to 6%
SDS–PAGE and autoradiography.
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